09:13 AM EST, 01/02/2025 (MT Newswires) -- Bioventus ( BVS ) said Thursday it has divested its Advanced Rehabilitation business under its Bioness unit to private equity firm Accelmed Partners.
The deal was first announced on Oct. 1 for a total cash consideration of $45 million.
Bioventus ( BVS ) said it gained net proceeds of about $20 million from the sale.
Shares of Bioventus ( BVS ) were down 2.4% in recent Thursday premarket activity.